Streetbeat News

Analyst Ratings

SWBI

Lake Street analyst Mark Smith maintains a Buy rating on Smith & Wesson Brands (NASDAQ:SWBI) and raises the price target from $14.5 to $16.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:25 pm

LEGN

RBC Capital analyst Leonid Timashev has reiterated an Outperform rating on Legend Biotech (NASDAQ:LEGN) and maintained a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:24 pm

SHW

BMO Capital analyst John McNulty has maintained an Outperform rating on Sherwin-Williams (NYSE:SHW) and increased the price target from $340 to $385.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:24 pm

ARKK

IYW

NVDA

SPRX

Ivana Delevska, founder of Spear Invest, is being compared to Cathie Wood due to her fund, Spear Alpha ETF (SPRX), outperforming ARK Innovation ETF (ARKK). While ARKK has seen significant outflows and flat performance in 2024, SPRX has surged 15% in the same period. Delevska's investment strategy, focusing on value and 'boots on the ground' research, contrasts with Wood's thematic approach. Delevska's success, especially in tech sectors like cybersecurity and semiconductors, has drawn attention and increased SPRX's AUM significantly.

Portfolio Pulse from Johnny Rice

March 08, 2024 | 4:23 pm

BJ

DA Davidson analyst Michael Baker maintains a Buy rating on BJ's Wholesale Club (NYSE:BJ) and raises the price target from $90 to $92.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:22 pm

KGS

RBC Capital analyst Elvira Scotto has reiterated an Outperform rating on Kodiak Gas Services (NYSE:KGS), maintaining a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:22 pm

MGNX

BMO Capital analyst Etzer Darout has maintained an Outperform rating on Macrogenics (NASDAQ:MGNX) and increased the price target from $18 to $24.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:22 pm

PHGE

HC Wainwright & Co. has reiterated its Buy rating on BiomX, but adjusted the price target from $7 to $2. This adjustment reflects a significant change in the valuation of the company.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:22 pm

LIN

BMO Capital analyst John McNulty has maintained an Outperform rating on Linde (NASDAQ:LIN) and increased the price target from $460 to $510.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 4:20 pm